Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3)

NCT03377491 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

571

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreas Adenocarcinoma

Interventions

DEVICE: NovoTTF-200T
DRUG: Gemcitabine
DRUG: nab paclitaxel

Sponsor

NovoCure Ltd.